FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Aspen Biopharma Labs Pvt. Finasteride NDC# 82187-1003-1 Container Recall

Finasteride NDC# 82187-1003-1 Container Description: The product packed in white poly…

Aspen Biopharma Labs Pvt., Ltd.

Risk level
Class II
Reported by FDA
Mar 19, 2025
Recall ID
D-0262-2025
Check your lot numberHow we source this data

Summary

Aspen Biopharma Labs Pvt. recalled Finasteride NDC# 82187-1003-1 Container starting Feb 7, 2025. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0262-2025 on Mar 19, 2025. Reason: CGMP Deviations. Status: Ongoing.

Why it was recalled

CGMP Deviations

Product description

Finasteride NDC# 82187-1003-1 Container Description: The product packed in white poly bag containing black poly bag and tied each individual finally packed in HDPE container for shipping.

Lot numbers, UPCs & expiration codes

Lot Numbers: HAFSC0040923, exp. date Aug-2027 HAFSC0050923, exp. date Aug-2027

Where it was sold

Product was distributed to 3 distributors (1 Hong Kong and 2 accounts in Florida)

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0262-2025
Classification
Class II
Status
Ongoing
Recall initiated
Feb 7, 2025
FDA report date
Mar 19, 2025
Quantity
120.0 kg
Recall type
Voluntary: Firm initiated
Recalling firm
Aspen Biopharma Labs Pvt., Ltd.

Original FDA data

Every field from FDA enforcement report D-0262-2025, exactly as published.

Show all FDA fields
City
Medchal Malkajgiri
Status
Ongoing
Country
India
Event ID
96209
Address
Plot No 10, Biotech Park Phase-II
Address (line 2)
Lalgadi Malakpet Village,Turkapally, Shameerpet Mandal
Code information
Lot Numbers: HAFSC0040923, exp. date Aug-2027 HAFSC0050923, exp. date Aug-2027
Report date
Mar 19, 2025
Product type
Drugs
Recall number
D-0262-2025
Classification
Class II
Recalling firm
Aspen Biopharma Labs Pvt., Ltd.
Product quantity
120.0 kg
Reason for recall
CGMP Deviations
Voluntary / mandated
Voluntary: Firm initiated
Product description
Finasteride NDC# 82187-1003-1 Container Description: The product packed in white poly bag containing black poly bag and tied each individual finally packed in HDPE container for shipping.
Distribution pattern
Product was distributed to 3 distributors (1 Hong Kong and 2 accounts in Florida)
Recall initiation date
Feb 7, 2025
Initial firm notification
Letter
Center classification date
Mar 9, 2025

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0262-2025, published Mar 19, 2025. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls